Autologous CAR T cell therapy is an immunotherapy that involves modifying a patient's T cells to recognize and attack cancer cells. This is done by extracting a patient's T cells from their blood, modifying them in a laboratory to express a chimeric antigen receptor (CAR) that targets a specific antigen on cancer cells, and then infusing the modified cells back into the patient.
read more..